| pubmed-article:15389222 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C0340293 | lld:lifeskim |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C0038257 | lld:lifeskim |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C0256103 | lld:lifeskim |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C0288672 | lld:lifeskim |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:15389222 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:15389222 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15389222 | pubmed:dateCreated | 2004-9-24 | lld:pubmed |
| pubmed-article:15389222 | pubmed:abstractText | Most patients with acute myocardial infarction (AMI) are admitted to hospitals without percutaneous transluminal coronary angioplasty (PTCA) facilities or are initially managed in a prehospital mobile unit. Thrombolysis remains the most readily available reperfusion treatment in those settings, but the optimal subsequent strategy in those patients is unclear. If a mechanical recanalization is likely to be performed in an emergency, it is probably desirable that the patient receives abciximab, the glycoprotein IIb/IIIa antagonist with the strongest evidence of benefit for angioplasty in AMI. | lld:pubmed |
| pubmed-article:15389222 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15389222 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15389222 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15389222 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15389222 | pubmed:issn | 1097-6744 | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:BologneseLeon... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:GuiducciVince... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:SteffeninoGiu... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:StegPhilippe... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:ZmudkaKrzyszt... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:IndolfiCiroC | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:DudekDariuszD | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:AiroldiFlavio... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:FlatherMarcus... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:OlivariZoranZ | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:ManariAntonio... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:PatriziGiampi... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:BelpommeVanes... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:MaillardLucL | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:GambaratiGiam... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:RusconiLuigi... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:PiovaccariGia... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:HibonAgnes... | lld:pubmed |
| pubmed-article:15389222 | pubmed:author | pubmed-author:PanzarasaRita... | lld:pubmed |
| pubmed-article:15389222 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15389222 | pubmed:volume | 148 | lld:pubmed |
| pubmed-article:15389222 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15389222 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15389222 | pubmed:pagination | 378-85 | lld:pubmed |
| pubmed-article:15389222 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:meshHeading | pubmed-meshheading:15389222... | lld:pubmed |
| pubmed-article:15389222 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15389222 | pubmed:articleTitle | Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). | lld:pubmed |
| pubmed-article:15389222 | pubmed:affiliation | Royal Brompton Hospital, London, United Kingdom. c.dimario@rbh.nthames.nhs.uk | lld:pubmed |
| pubmed-article:15389222 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15389222 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15389222 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15389222 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15389222 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15389222 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15389222 | lld:pubmed |
